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Quality of lifeAbstract Background: Idiopathic pulmonary ﬁbrosis (IPF) is a chronic lung condition of uncer-
tain etiology that causes progressive shortness of breath, cough, reduced exercise tolerance and
quality of life. This may, at least in part, be due to daily physical inactivity. Therefore symptomatic
patients with lung ﬁbrosis may be good candidates for comprehensive pulmonary rehabilitation
(PR) programs.
Aim of work: To evaluate the role of PR program in improving the functional status and dysp-
nea scale in patients with IPF.
Patients and methods: Thirty patients had IPF, according to the recent consensus statement, were
subjected to PR program that mainly consisted of three sessions per week for 8 week duration. The
program basically consisted of upper and lower extremity exercises, breathing exercise, and chest
physical therapy. Psychological support and patient education rounded out the program. Spirome-
tery, diffusion capacity of the lung for carbonmonoxide [DLco], arterial blood gas analysis, 6-minute
walking distance (6MWD), dyspnea rating with the Modiﬁed Borg Scale (MBS) and health-related
quality of life (HRQL) score using the St. George’s Respiratory Questionnaire (SGRQ) score were
evaluated at baseline, after 4 weeks and at the end of the eighth week of the program.
Results: There were signiﬁcant improvement in dyspnea score (P= 0.001), 6MWD (P= 0.001),
% predicted of forced vital capacity (FVC% predicted) (P= 0.001) and HRQL (P= 0.001).
However, arterial blood gas values and DLco showed no signiﬁcant improvement at the end of the
program.
Conclusions: PR improves dyspnea score, exercise capacity and HRQL in patients with IPF.
ª 2014 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.Introduction
Idiopathic pulmonary ﬁbrosis (IPF) is a chronic, progressive
ﬁbrosing interstitial pneumonia of unknown cause, occurring
primarily in older adults, limited to the lungs, and associated
with the histopathologic and/or radiologic pattern of usual
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the past 30 years, effective therapy for IPF remains elusive;
median survival rates have remained less than 5 years from
the time of diagnosis [1].
Beside medications that help IPF patients live longer, an
important question to ask is whether there are interventions
that might allow these people to live better; to be more active;
to experience less dyspnea, less depression, less anxiety; to pos-
sess a greater sense of control over their disease; and to have
better quality of life. Pulmonary rehabilitation (PR) helps to
accomplish many of these goals in patients with chronic
obstructive pulmonary disease (COPD), and emerging data
suggest that it may do the same for patients with IPF [2].
PR program has been deﬁned as an ‘‘evidence-based, mul-
tidisciplinary, and comprehensive intervention for patients
with chronic respiratory disease who are symptomatic and
often have decreased daily life activities [3]. PR is likely to
improve cardiovascular performance, muscle strength, and
mood disorders, and there have been several studies that sup-
port this contention. Unfortunately, none of these studies is
sufﬁciently large to conclusively demonstrate clinically mean-
ingful beneﬁts of PR in IPF patients [4]. The present study
aimed to evaluate the role of PR program in improvement of
pulmonary function, exercise capacity and health-related
quality of life (HRQL) of patients with IPF.
Patients and methods
Study participants
Thirty IPF patients (22 females and 8 males with mean age
54 years) were recruited in this prospective study. Those
patients were attended to at the outpatient clinic of the Chest
Department, El-Minya University Hospital. The diagnosis of
IPF was made in accordance with the ATS/ERS/JRS/ALAT
statement 2011 [1].
Exclusion criteria
Exclusion criteria were pulmonary ﬁbrosis not due to IPF, IPF
in exacerbation, severe comorbid illnesses, unable to walk
unassisted for balance and the need for long-term oxygen
therapy.
All patients were subjected to the following:
At baseline
Pulmonary function test using Spirometery (Cosmed SrL,
Quark PFTs ergo, P/N Co9035-12-99, Italy) to measure forced
vital capacity (FVC), % predicted of FVC, forced expiratory
volume in ﬁrst second (FEV1) and FEV1/FVC ratio. Diffusion
capacity of the lung for carbon monoxide [DLco] using single
breath method was measured using D 97723; Zan 300, Obe-
rthulba, Germany, CO/CH4 analyzer. Measurement of pH,
PaCO2, PaO2 and SaO2 using blood gases analyzer (Rapid
lab 850;CHIRON/Diagnostics; critical care systems) was done.
A six-minute walk test (6MWT) to measure the functional
exercise capacity, according to the ATS statement was carried
out [5]. It is the distance which the patient could walk as far as
possible in 6 min, the patient being allowed to stop and rest if
necessary. The distance was calculated in meters during followup. Dyspnea scale was assessed using Modiﬁed Borg Scale
(MBS). It is a valid and reliable tool for assessment of dyspnea.
MBS is a 10-point scale with a non-linear scaling scheme using
descriptive terms to anchor the responses from the participants
(0 = no dyspnea, 10 = very severe dyspnea) [6]. The St.
George’s Respiratory Questionnaire (SGRQ) was used to
assess HRQL. The SGRQ score comprises three component
scores (symptoms, activity, and impact) which sum to a total
score. Each component of the SGRQ score can range from 0
to 100 with a lower score denoting a better HRQL [7].Pulmonary rehabilitation program
Thirty IPF patients were subjected to the PR therapy basically
consisting of upper and lower extremity exercises, breathing
exercise, and chest physical therapy. Psychological support
and patient education rounded out the program. PR program
included three sessions per week for 8 weeks done in Rheuma-
tology and Rehabilitation Department, El-Minya University
Hospital.
1. Upper limb exercise included the following:
 Shoulder wheel which is used to increase the upper limb
exercise endurance in which the patient can perform
multiple movements of shoulder by changing his posi-
tion as abduction where the patient stands facing the
shoulder wheel and elevates the arm above the horizon-
tal plane and then externally rotates the shoulder, ﬂex-
ion and extension where the patient stands sideways
with involved shoulder toward the wheel. He then
moves the wheel forward and backward to the limits
of his range of motion.
 Wall pulley weight system: The patient may be sitting,
or standing and instructed to do shoulder ﬂexion and
abduction and hold one handle in each hand. The
elbow should be kept in extension if possible. The
patient then does internal and external rotations of
the abducted shoulder with the elbow ﬂexed 90 degrees.
2. Lower limb exercise included the following:
 Exercise bicycle: used to increase lower extremity
strength and endurance. It provides resistance to mus-
cles during repetitive, reciprocal movements of lower
extremities. It particularly appropriates for low inten-
sity high repetition exercises and designed to increase
muscular or cardiovascular endurance.
 Quadriceps strengthening exercise: The patient sits on
the devise and then ﬂexes and extends his Knee against
resistance with a series of increasing weights.
 Stair limb: The patient go up and down stair 4 times.
3. Breathing exercises included the following:
 Pursed lip breathing which involves a nasal inspiration
followed by expiratory blowing against partially closed
lips, avoiding forceful exhalation.
 Diaphragmatic breathing which consists of having the
patient inspire through the nose, making a conscious
effort to use only the diaphragm monitoring the out-
ward expansion of the abdomen with one hand while
attempting to minimize chest wall expansion with the
other.
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program (N= 30).
Variables Total N= 30
Age
Range 45–68
Mean ± SD 54.4 ± 6.1
Sex
Males 8 (26.7%)
Females 22 (73.3%)
Occupation No. (%)
Housewife 19 (63.3%)
Farmer 3 (10%)
Teacher 2 (6.7%)
Seller 2 (6.7%)
Driver 1 (3.3%)
Doorman 1 (3.3%)
Carpenter 2 (6.7%)
Smoking
Current smoker 1 (3.3%)
Ex smoker 2 (6.7%)
Non smoker 17 (56.7%)
Biomass fuel exposure 10 (33.3%)Re-evaluation at 4 and 8 weeks was carried out for assessment
of arterial blood gas ABG parameters, spirometric ﬁndings,
DLco, 6MWD, MBS dyspnea score and SGRQ for HRQL.
Statistical analysis
Data were analyzed by SPSS soft ware version 11, quantitative
data were presented as mean and standard deviation while
qualitative data were presented as frequency distribution.
Friedman, paired sample t test, independent t test and correla-
tions were used to test signiﬁcance. Probability of less than
0.05 was considered as cutoff level for signiﬁcance.
Results
Thirty patients were included in this prospective study. The
demographic data of the IPF patients under PR program are
shown in Table 1. After the program, there was a signiﬁcant
improvement in MBS dyspnea score, 6MWD, FVC% pre-
dicted and SGRQ score for HRQL compared by baseline vari-
ables but there was no signiﬁcant improvement in arterial
blood gas values or DLco values (Table 2)
Discussion
Patients with restrictive lung diseases often report decreases in
exercise tolerance, daily living activities, muscle force, HRQL,
and increases in levels of fatigue and dyspnea [8]. Although
ventilatory impairment and alterations in gas exchange may
obviously cause exercise limitation in these patients, peripheral
muscle weakness is increasingly recognized to contribute to
their disability and handicap [9]. Therefore symptomatic
patients with lung ﬁbrosis may be good candidates for compre-
hensive PR programs [10]. To date, the effects of (exercise-
based) PR program have mainly been studied in patients with
moderate to very severe COPD. Supervised comprehensive PR
programs have been shown to result in clinically relevant
improvements in quality of life and functional mobility in clin-
ically stable patients with moderate to very severe COPD,
without signiﬁcant improvements in their pulmonary function
[11]. The effects of exercise-based rehabilitation in patients
with other chronic lung diseases have not been extensively
studied [12].
The aim of our study was to evaluate the effect of PR pro-
grams in minimizing clinical impairment and disabilities and in
improving daily physical activities in IPF patients. We studied
thirty IPF patients, females were more than males (73% versus
26%) which was against the worldwide known notion that IPF
was common in elderly males. This may need further studies
on larger numbers of IPF patients and more statistical indices
in Egypt.
Dyspnea is one of the most prevalent symptoms that limits
exercise capacity in patients with IPF [13]. As regards MBS as
an assessment tool for perception of dyspnea, the present study
found a statistically signiﬁcant improvement in dyspnea scale
after PR program. It decreased from baseline by an average
value of 0.6 unit after 4 weeks (P= 0.001) and 1.3 unit after
8 weeks (P= 0.001). Similar results were documented with
Pulmonary rehabilitation in patients with idiopathic pulmonarFerreira et al [14] who studied 50 IPF patients before and after
4 weeks of exercise and educational activity programs and
found that at baseline the mean of Borg Score was decreased
by an average value of 1 unit after PR program
(P< 0.0001). Inpatient PR program for 4 weeks continued
later at home for up to 12 weeks on 31 IPF patients also
resulted in a signiﬁcant improvement in dyspnea sensation
(P< 0.01) and Borg scale in rehabilitated IPF patients [15].
Twenty-six IPF patients who underwent an 8-week PR pro-
gram in one study were followed up for a 1-year reassessment
[9]. That study reported a signiﬁcant reduction in the level of
perceived dyspnea assessed by MBS after 8 weeks of hospital
based outpatient PR. In addition, that study found that PR is
effective in improving exercise endurance and the quality of life
and in reducing hospital admissions in patients with pulmonary
ﬁbrosis. In contrast to our results, no improvement in dyspnea
after 10 weeks of PR program was reported in Nishiyama study
[16]. The pulmonary rehabilitation in this study was applied on
only 13 IPF patients and dyspnea was assessed by Baseline
Dyspnea Index (BDI). These two differences from the present
study may be the cause behind the difference in the results.
Activity monitoring is considered a highly relevant outcome
measure of respiratory rehabilitation. Functional exercise toler-
ance in patients with COPD is often assessed by the 6MWT and
in both COPD and ILD patients dyspnea level and 6MWT dis-
tance are predictors of mortality [17]. In the present study, a
statistically signiﬁcant improvement in the functional exercise
capacity assessed by the 6MWT was found after PR program.
6MWD increased by 30.5 meters (m) after 4 weeks with
(P= 0.001) and 60.6 m after 8 weeks (P= 0.001). This
increase in the exercise capacity may be attributed to increased
muscle endurance, cardiac and pulmonary performance and
decreased sensation of dyspnea after PR program. Several stud-
ies reported similar results with a signiﬁcant improvement of
6MWT after PR program [8,14,16,18,19].
Table 2 FVC% predicted, MBS, 6MWD, DLco, SGRQ, PaCO2 and PaO2 in rehabilitated IPF patients (At baseline, at 4 weeks and
at 8 weeks of PR program).
Variable At base line (Mean ± SD) At 4 weeks (Mean ± SD) At 8 weeks (Mean ± SD) P
FVC% predicted 51.9 ± 13.6 54.7 ± 13.5 57.3 ± 12.8 0.001
MBS of dyspnea 5 ± 1.2 4.4 ± 1.1 3.7 ± 1.1 0.001
6MWD 281.8 ± 64.7 312.3 ± 64.4 342.4 ± 60.01 0.001
SGRQ score 53.5 ± 19.5 32.6 ± 72.4 18.7 ± 15.2 0.001
PaO2 74.8 ± 8.7 76.3 ± 8.2 75.9 ± 8.1 0.2
PaCO2 40.1 ± 4.8 40.6 ± 4.2 40.06 ± 8.1 0.9
DLco % 62.2 ± 13.5 64.8 ± 12.6 66.5 ± 12.2 0.4
FVC %: % predicted of forced vital capacity, DLco: diffusion capacity for carbon monoxide, MBS: Modiﬁed Borg Scale, 6MWD: six minute
walking distance, SGRQ: The St. George’s Respiratory Questionnaire, PaCO2: partial pressure of carbon dioxide, PaO2: partial pressure of
oxygen.
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improvement in FVC% predicted after PR program. The
mean FVC% predicted was (51.9%), (54.7%) and (57.3%) at
baseline, after 4 weeks and after 8 weeks of PR program,
respectively (P= 0.001). Several studies support this observa-
tion, however despite improvement in FVC, the difference was
insigniﬁcant [14,16,20]. The cause of this difference was that
patients included in those studies had relatively mild impair-
ment in FVC % predicted (the mean FVC% predicted was
68.7%) while the mean FVC% predicted in the present study
was 51.9%. So, PR may be more effective in patients with
more severe disease. This point needs to be evaluated in
another study.
In fact, patients with advanced lung ﬁbrosis may be too
dyspneic to leave the house or to walk suggesting a clear lack
of regular daily physical activities in these patients [15].
Reduced daily physical activity may lead to loss of physical ﬁt-
ness and reduced quality of life seen in patients with chronic
lung disease [21]. In the present study, there was a statistically
signiﬁcant improvement in daily physical activity level and
HRQL assessed by SGRQ score after PR program. The mean
total score before PR program was (53.5 ± 19.5) and after PR
program was (18.7 ± 15.2) with (P= 0.001). Likewise, Jastr-
zebski et al. [15] found a statistically signiﬁcant improvement
in daily physical activities and in HRQL measured by SF-36
and SGRQ after 12 weeks of PR program. Also, Nishiyama
et al.’s [16] study found a statistically signiﬁcant improvement
in the total score of SGRQ score in rehabilitated IPF group
than the control group with (P< 0.01). Signiﬁcant improve-
ment in quality of life in rehabilitated IPF patients measured
by Chronic Respiratory Disease Questionnaire (CRDQ) and
by SGRQ score was also reported in another study [9].
In the present study, there was no statistically signiﬁcant
improvement in PaO2 or DLco values in rehabilitated IPF
patients between baseline, 4 weeks and 8 weeks. This was sup-
ported by Nishiyama et al. [16] who found no improvement in
PaO2 or DLco values after 10 weeks of PR program. This may
be explained by the possibility that PR program does not affect
the underlying thickening and ﬁbrosis of the alveolocapillary
membrane; the pathologic hallmark of IPF responsible for
impaired gas exchange and diffusion defects in those patients
although it improves oxygen consumption at muscle level.
The present study has some limitations. First, the study
sample was small and another study containing a large number
of patients will be needed to conﬁrm the results. Second, the
results were not based on the degree of pulmonary impairmentand whether patients with mild or severe impairment will ben-
eﬁt well from PR program is not known. Third, control group
was needed to conﬁrm the value of PR program in a speciﬁc
group of patients.Conﬂict of interest
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